BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9052836)

  • 1. Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6.
    Morse L; Chen D; Franklin D; Xiong Y; Chen-Kiang S
    Immunity; 1997 Jan; 6(1):47-56. PubMed ID: 9052836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.
    Schrantz N; Beney GE; Auffredou MT; Bourgeade MF; Leca G; Vazquez A
    J Immunol; 2000 Oct; 165(8):4346-52. PubMed ID: 11035070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
    Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK inhibitor p18(INK4c) is required for the generation of functional plasma cells.
    Tourigny MR; Ursini-Siegel J; Lee H; Toellner KM; Cunningham AF; Franklin DS; Ely S; Chen M; Qin XF; Xiong Y; MacLennan IC; Chen-Kiang S
    Immunity; 2002 Aug; 17(2):179-89. PubMed ID: 12196289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation.
    Kovalev GI; Franklin DS; Coffield VM; Xiong Y; Su L
    J Immunol; 2001 Sep; 167(6):3285-92. PubMed ID: 11544316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation.
    Franklin DS; Xiong Y
    Mol Biol Cell; 1996 Oct; 7(10):1587-99. PubMed ID: 8898364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis.
    Morrison RF; Farmer SR
    J Biol Chem; 1999 Jun; 274(24):17088-97. PubMed ID: 10358062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.
    Swarbrick A; Lee CS; Sutherland RL; Musgrove EA
    Mol Cell Biol; 2000 Apr; 20(7):2581-91. PubMed ID: 10713180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells.
    Yamato K; Koseki T; Ohguchi M; Kizaki M; Ikeda Y; Nishihara T
    Mol Endocrinol; 1997 Jul; 11(8):1044-52. PubMed ID: 9212052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
    Guan KL; Jenkins CW; Li Y; Nichols MA; Wu X; O'Keefe CL; Matera AG; Xiong Y
    Genes Dev; 1994 Dec; 8(24):2939-52. PubMed ID: 8001816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M; Muller WJ; Singh G; Graham FL
    Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells.
    Gupta S; Hussain T; Mukhtar H
    Arch Biochem Biophys; 2003 Feb; 410(1):177-85. PubMed ID: 12559991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
    Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
    J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
    Luedde T; Rodriguez ME; Tacke F; Xiong Y; Brenner DA; Trautwein C
    Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
    Noh SJ; Li Y; Xiong Y; Guan KL
    Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors.
    Jeffrey PD; Tong L; Pavletich NP
    Genes Dev; 2000 Dec; 14(24):3115-25. PubMed ID: 11124804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d).
    Zindy F; den Besten W; Chen B; Rehg JE; Latres E; Barbacid M; Pollard JW; Sherr CJ; Cohen PE; Roussel MF
    Mol Cell Biol; 2001 May; 21(9):3244-55. PubMed ID: 11287627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.